129 related articles for article (PubMed ID: 10880946)
1. [Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma].
Rebattu P; Coudert B; Schneider M; Ouabdesselam R; Lentz M; Hanauske A; Chevallierdagger B; Fumoleau P; Chollet P
Rev Pneumol Clin; 2000 Jun; 56(3):200-3. PubMed ID: 10880946
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
Mathé G; Misset JL; Triana BK; Godenèche D; Madelmont JC; Meyniel G
Drugs Exp Clin Res; 1992; 18(4):155-8. PubMed ID: 1451646
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
4. Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- or second-line treatment in advanced malignant melanoma: a trial of the EORTC Clinical Studies Group.
Cure H; Souteyrand P; Ouabdesselam R; Roche H; Ravaud A; D'incan M; Viens P; Fargeot P; Lentz MA; Fumoleau P; Hanauske A; Chollet P
Melanoma Res; 1999 Dec; 9(6):607-10. PubMed ID: 10661773
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
Peschel C; Hartmann JT; Schmittel A; Bokemeyer C; Schneller F; Keilholz U; Buchheidt D; Millan S; Izquierdo MA; Hofheinz RD
Lung Cancer; 2008 Jun; 60(3):374-80. PubMed ID: 18054408
[TBL] [Abstract][Full Text] [Related]
6. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.
Eisen T; Thatcher N; Leyvraz S; Miller WH; Couture F; Lorigan P; Lüthi F; Small D; Tanovic A; O'Brien M
Lung Cancer; 2009 Apr; 64(1):60-5. PubMed ID: 18692272
[TBL] [Abstract][Full Text] [Related]
9. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
[No Abstract] [Full Text] [Related]
10. Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.
Yoh K; Kubota K; Kakinuma R; Ohmatsu H; Goto K; Niho S; Saijo N; Nishiwaki Y
Lung Cancer; 2007 Oct; 58(1):73-9. PubMed ID: 17548127
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: a phase I-II trial.
Stathopoulos GP; Dimitroulis J; Toubis M; Katis C; Karaindros D; Stathopoulos J; Koutandos J
Lung Cancer; 2007 Jul; 57(1):66-71. PubMed ID: 17382431
[TBL] [Abstract][Full Text] [Related]
12. Some thoughts on surgical adjuvant studies in lung cancer.
Carter SK
Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
[No Abstract] [Full Text] [Related]
13. [Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer].
Yang L; Wang JW; Sun Y; Zhu YZ; Liu XQ; Li WL; Di LJ; Li PW; Wang YL; Song SP; Yao C; You LF
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):138-41. PubMed ID: 16750022
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
Onoda S; Masuda N; Seto T; Eguchi K; Takiguchi Y; Isobe H; Okamoto H; Ogura T; Yokoyama A; Seki N; Asaka-Amano Y; Harada M; Tagawa A; Kunikane H; Yokoba M; Uematsu K; Kuriyama T; Kuroiwa Y; Watanabe K;
J Clin Oncol; 2006 Dec; 24(34):5448-53. PubMed ID: 17135647
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
[No Abstract] [Full Text] [Related]
16. Initial therapeutic trial of new drugs in lung cancer.
Selawry OS
Cancer Chemother Rep 3; 1973 Mar; 4(2):215-25. PubMed ID: 4729325
[No Abstract] [Full Text] [Related]
17. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
19. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
Thongprasert S; Chewaskulyong B
J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]